We are currently conducting research into the potential use of Omnigen® (a dry preserved biological matrix, derived from human amnion) in the treatment of Diabetic Foot Ulcers (DFUs).
As part of this research we would like to gain a better understanding of the pathway for new products into this market. Please could you could spare 4 minutes of your time to complete a quick survey? If so, please click on the link below
Today we join the global movement to say no to violence against women. 25th November marks the International Day for the Elimination of Violence Against Women, and the start of the UN’s #OrangeTheWorld campaign – a call to action to end gender-based...
The newly published Defining the Size of the Health Innovation Prize report by Frontier Economics, commissioned by the Health Innovation Network, highlights a transformative opportunity for the UK. It sets out a bold, evidence-based case for strategic investment in...
Earlier this month, the government unveiled its latest commitment to accelerate access to cancer treatments through a so-called "red tape blitz". Headlines have trumpeted a simplified approval process for innovative therapies, claiming this will bring game-changing...